Cases & Deals

Jefferies acts as representative of initial purchasers in $250 million Rule 144A and Regulation S offering by Vantage Oncology, LLC and Vantage Oncology Finance and arranger of revolving credit facility for Vantage Oncology

Clients Jefferies LLC

Jones Day advised Jefferies LLC, as representative of the initial purchasers, in connection with the issuance of $250 million of 9 1/2% Senior Secured Notes due 2017 in a Rule 144A and Regulation S offering by Vantage Oncology, LLC and Vantage Oncology Finance Co., a leading provider of radiation oncology services. Jones Day also advised Jefferies Finance LLC, as arranger, administrative agent, collateral agent, and lender in connection with the concurrent $25 million revolving credit facility for Vantage Oncology.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.